| Literature DB >> 25949888 |
Marco Lepore1, Claudia de Lalla2, Lucia Mori3, Paolo Dellabona2, Gennaro De Libero3, Giulia Casorati2.
Abstract
A subset of CD1c-restricted T lymphocytes exhibits strong reactivity against leukemia cells. These T cells recognize methyl-lysophosphatidic acid (mLPA), a novel lipid antigen produced by acute leukemia cells. Considering that CD1c-restricted T cells display efficacious anti-leukemia activities in a mouse model, this lipid antigen thus represents a novel target in the immunotherapy of hematological malignancies.Entities:
Keywords: CD1; autoreactivity; immunesurveillance; immunotherapy; leukemia; lipid antigens
Year: 2014 PMID: 25949888 PMCID: PMC4404883 DOI: 10.4161/21624011.2014.970463
Source DB: PubMed Journal: Oncoimmunology ISSN: 2162-4011 Impact factor: 8.110